Glucagon Like Peptide-1 receptor imaging in individuals with Type 2 Diabetes
Open Access
- 9 September 2021
- journal article
- research article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 63 (5) , 794-800
Abstract
Introduction: The Glucagon Like Peptide-1 receptor (GLP1R) is a gut hormone receptor, intricately linked to regulation of blood glucose homeostasis via several mechanisms. It is an established and emergent drug target in metabolic disease. Positron Emission Tomography (PET) radioligand 68Ga-DO3A-VS-Exendin4 (68Ga-Exendin4) has the potential to enable longitudinal studies of the GLP1R in human pancreas. Methods:68Ga-Exendin4 PET/CT examinations were acquired in overweight to obese individuals with type 2 diabetes (T2D) (n = 13) as part of a larger target engagement study (NCT03350191). A scanning protocol was developed to optimize reproducibility (target amount of 0.5 MBq/kg, corresponding to 68Ga-Exendin4, but not in other abdominal tissues, was high but variable between individuals. There was no evidence of self-blocking of the GLP1R by the tracer in this protocol, despite the high potency of Exendin4. The results show that a full dynamic scan can be simplified to a short static scan, potentially increasing throughput and reduce patient discomfort. 68Ga-Exendin4 concentration in pancreas (i.e. GLP1R density) correlated inversely with the age of the individual, and had a tendency to correlate positively to BMI. However, the total GLP1R content in pancreas did not. Conclusion: In summary, we present an optimized and simplified 68Ga-Exendin4 scanning protocol, to enable reproducible imaging of the GLP1R in pancreas. 68Ga-Exendin4 PET may enable quantification of longitudinal changes of pancreatic GLP1R during the development in T2D, as well as target engagement studies of novel GLP-1 agonists.Keywords
This publication has 27 references indexed in Scilit:
- Determining Predictors of Early Response to Exenatide in Patients with Type 2 Diabetes MellitusJournal of Diabetes Research, 2015
- Pre-clinical evaluation of [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 for imaging of insulinomaNuclear Medicine and Biology, 2014
- Detection of Metastatic Insulinoma by Positron Emission Tomography With [68Ga]Exendin-4—A Case ReportThe Journal of Clinical Endocrinology & Metabolism, 2014
- Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging studyThe Lancet Diabetes & Endocrinology, 2013
- Regional Differences in Islet Distribution in the Human Pancreas - Preferential Beta-Cell Loss in the Head Region in Patients with Type 2 DiabetesPLOS ONE, 2013
- In Vivo Imaging of the Glucagonlike Peptide 1 Receptor in the Pancreas with 68Ga-Labeled DO3A-Exendin-4Journal of Nuclear Medicine, 2013
- The role of aging upon β cell turnoverJournal of Clinical Investigation, 2013
- Pancreatic β‐cell mass in European subjects with type 2 diabetesDiabetes, Obesity and Metabolism, 2008
- Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human SubjectsJournal of Cerebral Blood Flow & Metabolism, 1990
- Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. GeneralizationsJournal of Cerebral Blood Flow & Metabolism, 1985